- Home
- GLDD vs GHRS Comparison
GLDD vs GHRS Comparison
Compare GLDD & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- GHRS
- Stock Information
- Founded
- GLDD 1890
- GHRS 2018
- Country
- GLDD United States
- GHRS Ireland
- Employees
- GLDD N/A
- GHRS N/A
- Industry
- GLDD Military/Government/Technical
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- GLDD Industrials
- GHRS Health Care
- Exchange
- GLDD Nasdaq
- GHRS Nasdaq
- Market Cap
- GLDD 770.3M
- GHRS 774.1M
- IPO Year
- GLDD 2006
- GHRS 2021
- Fundamental
- Price
- GLDD $12.22
- GHRS $12.91
- Analyst Decision
- GLDD Buy
- GHRS Strong Buy
- Analyst Count
- GLDD 1
- GHRS 8
- Target Price
- GLDD $14.00
- GHRS $30.63
- AVG Volume (30 Days)
- GLDD 337.0K
- GHRS 194.6K
- Earning Date
- GLDD 11-04-2025
- GHRS 11-13-2025
- Dividend Yield
- GLDD N/A
- GHRS N/A
- EPS Growth
- GLDD 63.54
- GHRS N/A
- EPS
- GLDD 1.06
- GHRS N/A
- Revenue
- GLDD $830,567,000.00
- GHRS N/A
- Revenue This Year
- GLDD $13.73
- GHRS N/A
- Revenue Next Year
- GLDD $3.56
- GHRS N/A
- P/E Ratio
- GLDD $11.33
- GHRS N/A
- Revenue Growth
- GLDD 24.40
- GHRS N/A
- 52 Week Low
- GLDD $7.51
- GHRS $6.00
- 52 Week High
- GLDD $12.89
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- GLDD 59.48
- GHRS 47.30
- Support Level
- GLDD $11.94
- GHRS $12.36
- Resistance Level
- GLDD $12.30
- GHRS $13.37
- Average True Range (ATR)
- GLDD 0.27
- GHRS 0.78
- MACD
- GLDD 0.02
- GHRS -0.06
- Stochastic Oscillator
- GLDD 87.65
- GHRS 39.13
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.